AI English summary of an SEC filing — figures as filed
Procter & Gamble PGP&G said net sales for fiscal 2024 rose 2% to $84.0 billion. The company said higher pricing of 4% was partly offset by unfavorable foreign exchange of 2%, and that volume and mix were unchanged from the prior year.
Key points
AI summaryP&G said net sales for fiscal 2024 rose 2% to $84.0 billion. The company said higher pricing of 4% was partly offset by unfavorable foreign exchange of 2%, and that volume and mix were unchanged from the prior year.
The company said gross margin rose 350 basis points to 51.4% and SG&A as a percentage of net sales rose 200 basis points to 27.7%. It also reported a non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset.
Procter & Gamble said operating income rose $411 million (2%) to $18.5 billion, and net earnings rose $236 million (2%) to $15.0 billion. The company said diluted EPS rose $0.12 to $6.02 and that foreign exchange reduced net earnings by approximately $589 million.
The company said it announced additional restructuring in December 5, 2023 for certain Enterprise Markets, including Argentina and Nigeria. It said pre-tax restructuring costs for fiscal 2024 were $659 million, including approximately $216 million of non-cash translation losses.
Key figures
Fiscal year ended June 30, 2024
- Revenue
- $84.0B
- Operating income
- $18.5B
- Net income
- $14.9B
- EPS
- $6.02
- Operating cash flow
- $19.8B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Annual net sales up $84.0 billion; pricing 4% higher, currency 2% unfavorable
P&G said net sales for fiscal 2024 rose 2% to $84.0 billion. The company said higher pricing of 4% was partly offset by unfavorable foreign exchange of 2%, and that volume and mix were unchanged from the prior year.
Source · Based on the MD&A text of the filing
Gross margin 51.4%, SG&A ratio 27.7%, Gillette $1.3 billion impairment charge
The company said gross margin rose 350 basis points to 51.4% and SG&A as a percentage of net sales rose 200 basis points to 27.7%. It also reported a non-cash impairment charge of $1.3 billion ($1.0 billion after tax) on the Gillette intangible asset.
Source · Based on the MD&A text of the filing
Operating Income $18.5 billion, Net Earnings $15.0 billion, Diluted EPS $6.02
Procter & Gamble said operating income rose $411 million (2%) to $18.5 billion, and net earnings rose $236 million (2%) to $15.0 billion. The company said diluted EPS rose $0.12 to $6.02 and that foreign exchange reduced net earnings by approximately $589 million.
Source · Based on the MD&A text of the filing
Limited Market Portfolio Restructuring Costs $659 million
The company said it announced additional restructuring in December 5, 2023 for certain Enterprise Markets, including Argentina and Nigeria. It said pre-tax restructuring costs for fiscal 2024 were $659 million, including approximately $216 million of non-cash translation losses.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…